The group’s principal activity is to research and development of novel all-natural drugs. The group products include AMZ0026-H, AMZHG001 and AZC0027. The group operates from the United States
Executive Information
Name
Title
Email
Simcha Edell
Dir., CFO
N/A
Angelo Chinnici
Member - Scientific Advisory Board
N/A
Anthony Mangia
Member - Scientific Advisory Board
N/A
Arthur Englard
Member - Scientific Advisory Board, Scientific Dir.
